Literature DB >> 19548060

Juvenile seropositive myasthenia gravis with anti-MuSK antibody after thymectomy.

Anna Kostera-Pruszczyk, Hubert Kwiecinski.   

Abstract

We report the case of a 17.5-year old girl with generalized myasthenia gravis (MG). When she was 13, she started to complain of episodic diplopia, ptosis and mild fatigability of upper and lower extremity muscles. She was diagnosed with MG 3 years later, after exacerbation of her limb muscle weakness. Acetylcholine receptor antibody was positive (2.56 nmol/l, n < 0.4 nmol/l), anti-MuSK antibodies were not tested at that time. She was treated with a thymectomy. After the operation a gradual worsening of her MG was seen; she reported pirydostygmine intolerance. On retesting, acetylcholine receptor antibodies were negative and she was positive for anti-MuSK antibodies. She received immunosuppressive treatment with prednisone and azathioprine with clinical improvement. She is the third reported patient diagnosed with acetylcholine receptor antibody-positive MG, who became MuSK-positive after thymectomy. Recognition of such clinical patterns may be important for decision making in myasthenia gravis patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19548060     DOI: 10.1007/s00415-009-5215-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  11 in total

1.  Infantile onset myasthenia gravis with MuSK antibodies.

Authors:  H Murai; T Noda; E Himeno; Y Kawano; Y Ohyagi; H Shiraishi; M Motomura; J Kira
Journal:  Neurology       Date:  2006-07-11       Impact factor: 9.910

2.  Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.

Authors:  Bilal Saulat; Paul Maertens; William J Hamilton; Bassam A Bassam
Journal:  Neurology       Date:  2007-08-21       Impact factor: 9.910

3.  The ageing and myasthenic thymus: a morphometric study validating a standard procedure in the histological workup of thymic specimens.

Authors:  Philipp Ströbel; Regina Moritz; Maria Isabel Leite; Nick Willcox; Wen-Yu Chuang; Ralf Gold; Wilfred Nix; Berthold Schalke; Reinhard Kiefer; Hans-Konrad Müller-Hermelink; Alfred Jaretzki Iii; John Newsom-Davis; Alexander Marx
Journal:  J Neuroimmunol       Date:  2008-07-25       Impact factor: 3.478

4.  MuSK-antibody positive myasthenia gravis: questions from the clinic.

Authors:  Donald B Sanders; Vern C Juel
Journal:  J Neuroimmunol       Date:  2008-08-05       Impact factor: 3.478

5.  Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.

Authors:  W Hoch; J McConville; S Helms; J Newsom-Davis; A Melms; A Vincent
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

6.  Myasthenia gravis seronegative for acetylcholine receptor antibodies.

Authors:  Angela Vincent; Maria Isabel Leite; Maria Elena Farrugia; Saiju Jacob; Stuart Viegas; Hiro Shiraishi; Olivier Benveniste; B Paul Morgan; David Hilton-Jones; John Newsom-Davis; David Beeson; Nick Willcox
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

7.  Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 1. Relation to clinical parameters in 250 patients.

Authors:  P C Limburg; T H The; E Hummel-Tappel; H J Oosterhuis
Journal:  J Neurol Sci       Date:  1983-03       Impact factor: 3.181

8.  MuSK-positive myasthenia gravis is rare in the Polish population.

Authors:  A Kostera-Pruszczyk; A Kamińska; M Dutkiewicz; B Emeryk-Szajewska; M H Strugalska-Cynowska; A Vincent; H Kwieciński
Journal:  Eur J Neurol       Date:  2008-05-20       Impact factor: 6.089

9.  Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.

Authors:  Amelia Evoli; Pietro A Tonali; Luca Padua; Mauro Lo Monaco; Flavia Scuderi; Anna P Batocchi; Mariapaola Marino; Emanuela Bartoccioni
Journal:  Brain       Date:  2003-06-23       Impact factor: 13.501

10.  Clinical aspects of MuSK antibody positive seronegative MG.

Authors:  D B Sanders; K El-Salem; J M Massey; J McConville; A Vincent
Journal:  Neurology       Date:  2003-06-24       Impact factor: 9.910

View more
  7 in total

Review 1.  Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.

Authors:  Michael H Rivner; Mamatha Pasnoor; Mazen M Dimachkie; Richard J Barohn; Lin Mei
Journal:  Neurol Clin       Date:  2018-05       Impact factor: 3.806

Review 2.  Clinically biphasic myasthenia gravis with both AChR and MuSK antibodies.

Authors:  Sanjeev Rajakulendran; Stuart Viegas; Jennifer Spillane; Robin S Howard
Journal:  J Neurol       Date:  2012-09-07       Impact factor: 4.849

3.  Juvenile Generalized Myasthenia Gravis With AChR and MuSK Antibody Double Positivity: A Case Report With a Review of the Literature.

Authors:  XiuShan Ge; CuiJie Wei; Hui Dong; YueHua Zhang; XinHua Bao; Ye Wu; DanYu Song; HongJun Hao; Hui Xiong
Journal:  Front Pediatr       Date:  2022-05-11       Impact factor: 3.569

4.  Switch to double positive late onset MuSK myasthenia gravis following thymomectomy in paraneoplastic AChR antibody positive myasthenia gravis.

Authors:  Berit Jordan; Susanne Schilling; Stephan Zierz
Journal:  J Neurol       Date:  2015-12-08       Impact factor: 4.849

5.  Juvenile myasthenia gravis: a paediatric perspective.

Authors:  Maria F Finnis; Sandeep Jayawant
Journal:  Autoimmune Dis       Date:  2011-11-01

6.  Myasthenic Crisis Complicated with Myxedema, Positive for Both Anti-acetylcholine Receptor and Anti-muscle-specific Tyrosine Kinase Antibodies.

Authors:  Kazuhiro Horiuchi; Azusa Nagai; Masahiro Wakita; Shotaro Ito; Kei Takamura; Hideki Houzen
Journal:  Intern Med       Date:  2017-11-01       Impact factor: 1.271

Review 7.  Complicating autoimmune diseases in myasthenia gravis: a review.

Authors:  Aliona Nacu; Jintana Bunpan Andersen; Vitalie Lisnic; Jone Furlund Owe; Nils Erik Gilhus
Journal:  Autoimmunity       Date:  2015-04-27       Impact factor: 2.815

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.